Google AI ModeSep 1, 2026
Luminex Multiplex Assays: Balances moderate-to-high multiplexing capabilities with reasonable sensitivity (low pg/mL range) and efficient sample volume usage.
Data as of Oct 7, 2026Based on 52 AI responses
Reviewed by Dimitry Apollonsky ·
Diasorin is a global diagnostic company that develops immunodiagnostic and molecular diagnostic solutions for infectious diseases, gastrointestinal diseases, hepatitis/retroviruses, endocrinology, metabolic disorders, tumor markers, and related conditions. It provides instruments (such as LIAISON XL/XS and VERIGENE) and a broad portfolio of kits, reagents, microspheres, and software to enable automated, high-precision testing, along with training and service support. The company also collaborates with Luminex to offer xMAP technology and related systems, kits, and education resources to expand multiplex testing capabilities.
Products
40%47% before. Down 7 points.
of AI answers about Luminex and its rivals. Since Jul 5
1
Question: Which platform maps biomarkers to assays with practical comparisons?
Google AI ModeSep 1, 2026
Luminex Multiplex Assays: Balances moderate-to-high multiplexing capabilities with reasonable sensitivity (low pg/mL range) and efficient sample volume usage.
Since Jul 5
Luminex's share in each topic, as its page ranks it
The market map
Biopharma Research Platforms and ServicesMentioned in
Where Luminex ranks in AI
Question: Which platform maps biomarkers to assays with practical comparisons?
Google AI ModeJul 3, 2026
Luminex: Uses bead-based assays with fluorescent detection for multiplexing.
Position in the answer
Weeks of Aug 24 – Sep 27, 2026
int.diasorin.com 0%Other sites 100%
Excerpts where Luminex appeared in the AI's answer
Luminex Multiplex Assays: Balances moderate-to-high multiplexing capabilities with reasonable sensitivity (low pg/mL range) and efficient sample volume usage.
Luminex: Uses bead-based assays with fluorescent detection for multiplexing.
